Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

16.05
Delayed Data
As of Feb 16
 -0.05 / -0.31%
Today’s Change
11.85
Today|||52-Week Range
19.46
+15.05%
Year-to-Date

Today’s Trading

Previous close16.10
Today’s open16.10
Day’s range15.95 - 16.48
Volume523,711
Average volume (3 months)786,843
Market cap$1.2B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+76.52%
Earnings growth (this year)-300.10%
Earnings growth (next 5 years)--
Revenue growth (last year)+22.27%
P/E ratioNM
Price/Sales9.43
Price/Book3.07

Competitors

 Today’s
change
Today’s
% change
SGMOSangamo Therapeutics...+0.30+1.30%
XLRNAcceleron Pharma Inc-0.50-1.18%
----
EPZMEpizyme Inc-0.50-2.68%
Data as of 4:00pm ET, 02/16/2018

Financials

Last reporting dateFebruary 15, 2018
EPS forecast (this quarter)$0.01
Annual revenue (last year)$109.6M
Annual profit (last year)-$21.0M
Net profit margin-19.16%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Operating Officer &
Chief Scientific Officer
Ganesh Venkataraman Kaundinya
Corporate headquarters
Cambridge, Massachusetts

Forecasts